Rabbit Anti-Human IgG H&L (HRP) (ab6759)

Reviews (1) Submit a question References (63)
ELISA - Rabbit Anti-Human IgG H&L (HRP) (ab6759)

    Key features and details

    • Rabbit Anti-Human IgG H&L (HRP)
    • Conjugation: HRP
    • Host species: Rabbit
    • Isotype: IgG
    • Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IF, Competitive ELISA

    Conjugates logo Related conjugates and formulations

    Alkaline Phosphatase Biotin DyLight® 488 DyLight® 550 DyLight® 594 DyLight® 650 FITC Texas Red ® TRITC Unconjugated Unconjugated

    製品の概要

    • 製品名

      Rabbit Anti-Human IgG H&L (HRP)
      IgG 二次抗体 製品一覧

    • 由来種

      Rabbit

    • ターゲット生物種

      Human

    • アプリケーション

      適用あり: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IF, Competitive ELISAmore details

    • 免疫原

      human IgG whole molecule

    • 標識

      HRP

    製品の特性

    • 製品の状態

      Liquid

    • 保存方法

      Shipped at 4°C. Store at +4°C.

    • バッファー

      Preservative: 0.01% Gentamicin sulphate
      Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride, 1% BSA
    • Concentration information loading...

    • 精製度

      Affinity purified

    • 特記事項（精製）

      This product was prepared from monospecific antiserum by immunoaffinity chromatography using human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.

    • 特記事項（標識）

      Horseradish Peroxidase (HRP)

    • ポリ/モノ

      ポリクローナル

    • アイソタイプ

      IgG

    • 研究分野

    アプリケーション

    The Abpromise guarantee

    Abpromise保証は、 次のテスト済みアプリケーションにおけるab6759の使用に適用されます

    アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。

    アプリケーション Abreviews 特記事項
    Dot blot
    Use at an assay dependent dilution.
    ELISA (1)
    1/130000.
    IHC-P
    Use at an assay dependent dilution.
    IHC-Fr
    Use at an assay dependent dilution.
    Immunomicroscopy
    Use at an assay dependent dilution.
    WB
    1/5000 - 1/25000.
    ICC/IF
    1/1000 - 1/5000.
    Competitive ELISA
    Use at an assay dependent dilution. PubMed: 20573830
    特記事項
    Dot blot
    Use at an assay dependent dilution.
    ELISA
    1/130000.
    IHC-P
    Use at an assay dependent dilution.
    IHC-Fr
    Use at an assay dependent dilution.
    Immunomicroscopy
    Use at an assay dependent dilution.
    WB
    1/5000 - 1/25000.
    ICC/IF
    1/1000 - 1/5000.
    Competitive ELISA
    Use at an assay dependent dilution. PubMed: 20573830

    画像

    • ELISA - Rabbit Anti-Human IgG H&L (HRP) (ab6759)
      ELISA - Rabbit Anti-Human IgG H&L (HRP) (ab6759)

      ELISA results of ab6759 tested against purified human IgG protein.

      Each well was coated in duplicate with 1.0 µg of human IgG. The starting dilution of antibody was 5 µg/ml and the X-axis represents the Log 10 of a 3-fold dilution. This titration is a 4-parameter curve fit where the IC50 is defined as the titer of the antibody. Assay performed using 3% fish gelatin as blocking buffer and TMB substrate.

    プロトコール

    To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

    Click here to view the general protocols

    参考文献 (63)

    ab6759 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

    ab6759 は 63 報の論文で使用されています。

    • Bühler L  et al. Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control. Life Sci Alliance 4:N/A (2021). PubMed: 33536239
    • Sotoudegan F  et al. Anti-Aß-scFv-loaded polymeric nano-micelles with enhanced plasma stability. J Pharm Pharmacol 73:460-472 (2021). PubMed: 33793837
    • Yusupov M  et al. Oxidative damage to hyaluronan-CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy. Redox Biol 43:101968 (2021). PubMed: 33895486
    • Iizasa E  et al. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun 12:2299 (2021). PubMed: 33863908
    • Fan J  et al. Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo. Oncol Lett 21:99 (2021). PubMed: 33376532
    View all Publications for this product

    レビューと Q&A

    Show All レビュー Q&A
    レビューを送る 質問を送る

    Intracellular Alpha-galactosidase A/antibody-complex detection from enzyme-treated EA.hy926 cells

     Excellent
    Abreviews
    abreview image
    Application
    ELISA
    Cells were seeded on 96-well plates with a density of 2x105 cell/ml and grown until confluent. After 4 hours of incubation with human recombinant α-galactosidase A (AGAL, 4.6 μg/ml) and patients’ serum (50 µl per 4.6 μg/ml AGAL), cells were washed twice with PBS and lysed with passive lysis buffer (Promega, Mannheim Germany). Lysates were centrifuged (14.000x g) for 20 minutes at 4°C and supernatants were used for ELISAs, as follows. 96 well plates were coated with a capture antibody (α-AGAL, R&D Sytems, Minneapolis, US no. AF6146, 200 ng per well) over night at 4°C. After 5 washes with 200 μl PBS/Tween 0.1% and blocking with PBS/BSA 2% for 2 hours at RT, 3-10 μl of cellular lysates were applied in 100 μl PBS overnight at 4°C. Wells were washed 3 times with PBS/Tween 0.1%. For human IgG detection shuttled into cells by AGAL, anti-hIgG HRP-coupled antibodies (Abcam no: ab6759, working concentration: 0.66 μg/ml) were applied in PBS/BSA 2% for 2 hours at RT. After 5 additional washes, 100 μl 1-Step Ultra TMB-ELISA Substrate Solution (Thermo Fisher Scientific) was added to each well, incubated at RT, and stopped with 100 μl 2 mol/l sulfuric acid. Absorption was measured at 450 nm and normalized for protein content and against serum from a healthy control (negativ for antibodies against AGAL).

    Figure legend: *p<0.05, **p<0.01.

    Abcam user community

    Verified customer

    投稿 Sep 04 2019

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com